PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 6, 20260 citationsOpen Access

Oral Fast-Dissolving Films as Carriers for Solid Dispersion Systems: A Review

View Full Paper
ASAnanya M. S.* Parthiban S.

Key Points

  • To evaluate the potential of fast dissolving oral films as carriers for solid dispersion systems in drug delivery.
  • Reviewed various solid dispersion techniques for improving drug solubility and dissolution.
  • Analyzed different polymers used in fast dissolving oral films.
  • Compared physicochemical properties of fast dissolving oral films and conventional dosage forms.
  • Fast dissolving oral films show improved drug release rates compared to traditional forms.
  • Solid dispersion techniques enhance drug solubility and absorption.
  • FDOFs are particularly beneficial for patients with swallowing difficulties.

Abstract

Fast dissolving oral films (FDOFs) have emerged as an advanced oral drug delivery system aimed at improving patient compliance, rapid onset of action, and bioavailability, particularly for poorly water-soluble drugs. Oral delivery remains the most preferred route due to its convenience and cost-effectiveness; however, limitations such as poor solubility and first-pass metabolism necessitate innovative approaches. FDOFs disintegrate rapidly in the oral cavity without the need for water, allowing pre-gastric absorption through buccal and sublingual mucosa. The incorporation of solid dispersion techniques—such as melting, solvent evaporation, hot melt extrusion, and lyophilization enhances drug solubility, dissolution rate, and uniformity by reducing particle size and crystallinity. Various polymers including HPMC, pullulan, PVA, starch derivatives, and xanthan gum have demonstrated excellent film-forming properties and rapid disintegration. Literature findings confirm that FDOFs exhibit superior physicochemical characteristics, faster drug release, and improved therapeutic efficacy compared to conventional dosage forms, making them a promising alternative for pediatric, geriatric, and dysphagic patients.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ananya M. S.* Parthiban S. (2026) studied this question.

synapsesocial.com/papers/698585db8f7c464f23009a25https://doi.org/10.5281/zenodo.18480754
Ask AI
Helpful
Bookmark
Share
View Full Paper